Astreas Shines at TechCrunch Disrupt, Biotech IPOs Surge
Simply Startups

Astreas Shines at TechCrunch Disrupt, Biotech IPOs Surge

2024-10-07
Astreas, an AI-powered human performance startup, is set to showcase its innovative solutions at TechCrunch Disrupt 2024. Meanwhile, three biotech startups are targeting up to $400 million in IPOs, capitalizing on a booming healthcare market. Additionally, 35 Indian startups presented their groundbreaking ideas at a NASSCOM event in Silicon Valley, while Cookie Finance raises $4.1 million to support social media content creators with tailored financial services. Join us as we explore the latest trends in startup...
View more
Comments (3)

More Episodes

All Episodes>>

Get this podcast on your phone, Free